Ingevity (NYSE: NGVT) reported Q2 EPS of $1.01, $0.04 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $390.6 million versus the consensus estimate of $407.58 million.

GUIDANCE:

Ingevity sees FY2024 revenue of $1.4-1.5 billion, versus the consensus of $1.489 billion. And adjusted EBITDA between $350 million and $360 million.

For earnings history and earnings-related data on Ingevity (NGVT) click here.